Varicella zoster virus vaccine live - Osaka University/Takeda

Drug Profile

Varicella zoster virus vaccine live - Osaka University/Takeda

Alternative Names: Freeze-dried live attenuated varicella vaccine - Osaka University/Takeda

Latest Information Update: 24 Jan 2014

$50 / €47 *
* $ price applies to USA, Canada and Latin America. € price applies to the rest of the world. Final gross prices may vary according to local VAT.

At a glance

  • Originator Osaka University
  • Class Varicella vaccines; Viruses
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Varicella zoster virus infections

Most Recent Events

  • 14 Jan 2014 Osaka University's live attenuated varicella zoster virus vaccine licensed to Takeda in Japan
  • 31 Dec 1988 Launched for Varicella zoster virus infections (in children, prevention) in Japan (Parenteral)
  • 31 Dec 1974 Clinical trials in Varicella zoster virus infections (in children, prevention) in Japan (Parenteral)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top